NexGenEsis Healthcare is a small, emerging healthcare franchise system offering non-surgical pain management and neuropathy treatment services. With only 14 total units and 6 franchised locations as of 2024, the system is in early development stages. The franchise requires a $55,000 initial fee with total investments ranging from $168,250 to $362,695. The business model includes both clinic management and healthcare center operations, with ongoing royalties of 7% of gross sales or $500 minimum monthly. Key concerns include the small system size, high unit closure rate in 2024 (4 of 14 units), and limited financial performance data. The franchise offers territory protection based on population (175,000-200,000 persons) and provides comprehensive training and support. Potential franchisees should carefully consider the early-stage nature of this system and limited track record.
Generated from 2025 Franchise Disclosure Document
AI-generated from FDD analysis — use as a checklist with your attorney
Total startup costs, working capital, and financial requirements
Training, marketing support, technology, and operational assistance
Royalty, marketing, technology, and other ongoing fees
Revenue data, P&L estimates, and financial projections
Lawsuits, disputes, and legal risk assessment
Territory rights, term length, non-compete, and transfer rules
82 legal provisions scored on a franchisee-friendliness scale
Unit growth trends, exit rates, and system trajectory
Similar to NexGenEsis Healthcare in category and investment range